Global Amniocentesis Needle Market Attractiveness, Competitive Landscape and Forecasts to 2023
The Global Amniocentesis Needle Market is expected to register a CAGR of about 5.4% over the forecast period, 2018-2023. Amniocentesis is a procedure that is used for the diagnosis of fetal defects in the second trimester of pregnancy. A sample from the amniotic fluid, surrounding the fetus in the womb, is collected through a pregnant woman's abdomen using a needle and syringe. Major Players: BECTON, DICKINSON AND COMPANY, BIOPSYBELL, COOK MEDICAL, COOPERSURGICAL, INTEGRA LIFESCIENCES, LABORATOIRE CCD, MEDLINE, MEDTRONIC, RI.MOS., ROCKET MEDICALAND SMITHS MEDICAL, TSUNAMI MEDICAL, amongst others.
Request a PDF Sample of this Global Amniocentesis Needle Market Report at: http://orbisresearch.com/contacts/request-sample/2213805?utm_source=Dipali
High Reliability of Amniocentesis
Amniocentesis is 99.4% accurate. This test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. Other testing techniques, like ultrasounds, pick up on the genetic defects or problems that might be there in the fetus. However, only amniocentesis can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, this market is expected to expand during the forecast period. Other factors, such as, the growth in the median age of first-time motherhood and heavy burden of congenital disorders are also expected to drive the market studied.
Availability of Alternate Methods
Amniocentesis is an invasive procedure where a needle in inserted into the womb of the mother for the collection of amniotic fluid, in order to study the possibility of prenatal disorders. Although Amniocentesis is a fairly safe procedure, there are occasional cases where it may lead to miscarriages, as the procedure involves invasive methods. Due to this, many pregnant women prefer the usage of alternative testing options, such as noninvasive prenatal test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening, among others. This is expected to slow down the growth of the amniocentesis needle market.
Amniocentesis is 99.4% accurate. This test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. Other testing techniques, like ultrasounds, pick up on the genetic defects or problems that might be there in the fetus. However, only amniocentesis can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, this market is expected to expand during the forecast period. Other factors, such as, the growth in the median age of first-time motherhood and heavy burden of congenital disorders are also expected to drive the market studied.
Availability of Alternate Methods
Amniocentesis is an invasive procedure where a needle in inserted into the womb of the mother for the collection of amniotic fluid, in order to study the possibility of prenatal disorders. Although Amniocentesis is a fairly safe procedure, there are occasional cases where it may lead to miscarriages, as the procedure involves invasive methods. Due to this, many pregnant women prefer the usage of alternative testing options, such as noninvasive prenatal test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening, among others. This is expected to slow down the growth of the amniocentesis needle market.
Browse the complete report on Global Amniocentesis Needle Market at: http://orbisresearch.com/reports/index/global-amniocentesis-needle-market-segmented-by-type-procedure-end-user-and-geography-growth-trends-and-forecast-2018-2023?utm_source=Dipali
Key Developments:
• March 2018 - A team of researchers led by Brock A. Peters, PhD, of Complete Genomics in San Jose, California, have shown that amniocentesis linked with whole-genome sequencing (WGS) can be used to analyze a fetus' entire genome for harmful mutations. Peters' team collected amniotic fluid from 31 pregnant women and isolated DNA from both the amniotic fluid and the fetal cells within it.
Reasons to Purchase the Report
• Current and future amniocentesis needle market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
• March 2018 - A team of researchers led by Brock A. Peters, PhD, of Complete Genomics in San Jose, California, have shown that amniocentesis linked with whole-genome sequencing (WGS) can be used to analyze a fetus' entire genome for harmful mutations. Peters' team collected amniotic fluid from 31 pregnant women and isolated DNA from both the amniotic fluid and the fetal cells within it.
Reasons to Purchase the Report
• Current and future amniocentesis needle market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Enquire For Buying Global Amniocentesis Needle Market Report at: http://orbisresearch.com/contacts/enquiry-before-buying/2213805?utm_source=Dipali
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Comments
Post a Comment